Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT01278160
Eligibility Criteria:
Inclusion Criteria:
* Finalised 24 weeks of treatment with once daily BIAsp 30 or insulin glargine in combination with metformin and glimepiride in trial BIAsp-3756
* HbA1c above or equal to 7.0%
* Body Mass Index (BMI) below or equal to 40.0 kg/m2
Exclusion Criteria:
* Known hypoglycaemia unawareness or recurrent major hypoglycaemic episodes in trial BIAsp-3756
* Known proliferative retinopathy or maculopathy requiring acute treatment
* Any disease or condition which the Investigator (trial physician) feels would interfere with the trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT01278160
Study Brief:
Protocol Section:
NCT01278160